retatrutide type 2 diabetes More data on dropped today at the ADA conference!! Reta is an investigational -not FDA approved yet- once-weekly medication that simultaneously activates the GIP, GLP-1, and glucagon receptors In the Phase retatrutide phase 2 trial type

Clinical Trial Enrollment The best option if you qualify

Nonsteroidal mineralocorticoid receptor antagonist Finerenone has recently been investigated in people with DKD (defined as an albumin to creatinine ratio of at least 3 mg/mmol and eGFR of 25 to 75 mL/min/1.73 m 2 ) who were treated with reninangiotensin system inhibitors

Personalized Monitoring and Care : Dr

A Dietitian's Honest Guide Written by Marina Savelyeva, MS, RDN, LD | Medically Reviewed | Updated March 2026 Focus on lean protein, high-fiber vegetables and whole grains, and healthy fats these food groups work alongside GLP-1 medications, not just around them